Lumens Bios루멘스바이오스

Lumens Bios trades near ₩1,000 after a steep fall, while its filings show a shift toward acquisitions and financing activity.

Lumens Bios, which makes LED chips and modules, light guide plates and automotive lighting electronics, reported trailing revenue of about ₩163.8B to H1 2026 but an operating loss of about ₩4.7B. Its share price is down 28.1% over one year and sits near its 52-week low, with the company's shares trading at roughly 0.2 times book value. Recent filings and headlines centre on an acquisition of stakes in Polaris Uno, a convertible bond decision, and a shareholders' meeting.

What stands out

• Trailing revenue is about ₩163.8B, but the trailing operating margin is -2.9% and net income is slightly negative at about -₩0.8B.
• Full-year 2025 net loss was about ₩6.7B, after a net profit of about ₩8.8B in 2024.
• Cash is about ₩62.6B against borrowings of only about ₩0.1B, and trailing free cash flow is about ₩7.1B.
• October 2026 headlines report an acquisition of Polaris Uno shares for about ₩13.8B to ₩57.3B, securing a 34% stake, according to news reports.
• Foreign ownership fell from 6.3% to 5.2% over the past 60 days, and 20-day flows show foreign buying against domestic selling.

What to watch

• Details and funding of the Polaris Uno acquisition and the terms of the convertible bond issue, as shown in upcoming filings.
• Outcome of the shareholders' meeting and the rights offering and capital reduction items in recent filings.
• Whether operating results return to profit, since the data shows operating losses in 2025 and the trailing period.